Caution Is Advisable

Although laboratory tests have demonstrated that resveratrol might help prevent cardiovascular disease and cancer, there are several reasons why a population-wide increase would be premature.

- The research on resveratrol has focused on its short-term effects and has been dominated by in vitro (laboratory) studies on non-human models.

- Not enough is known about the absorption and clearance of resveratrol, the identities of its metabolic products, or its effects on the liver.

- Resveratrol's role as a potentiator of breast carcinomas may significantly limit its use.

-  While taking resveratrol pills is certainly safer than heavy wine consumption, supplementing with unproven substances is generally unwise. At this point, occasional use of red wine seems far more prudent.

The Bottom Line

Epidemiologic studies can find associations between the consumption of foods or dietary supplements and various health outcomes. Animal experiments can demonstrate what can happen in the species tested. However, only human clinical trials can determine whether supplementation is useful for humans. Resveratrol has not been tested in clinical trials, and most clinical trials of other antioxidants have failed to demonstrate the benefits suggested by preliminary studies. Some substances—most notably beta-carotene—have even produced adverse effects. My advice is to ignore the hype surrounding resveratrol and eat a balanced diet that contains adequate amounts of fruits and vegetables.

Resveratrol Hype, Don't buy the hype